Show Summary Details
Page of

Transplant immunology 

Transplant immunology
Transplant immunology

Phillip Ruiz

, Junichiro Sageshima

, George Burke

, Linda Chen

, and Gaetano Ciancio

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 14 August 2020

The identification of the intricate and multiple means by which the immune system serves as a principal impediment to solid organ graft survival has given rise to the development of an increasing number of highly effective immunosuppressive agents. At this point in time, additional ways of interrupting and negating the immune pathways have resulted in improved short-term graft survival and lessened patient mortality. Unfortunately, immunosuppressive drug-associated toxicities still remain as a serious set of transplant morbidities and long-term graft survival is currently remaining at unacceptably high levels. As our understanding of the precise mechanisms of immune effector and enhancement mechanisms evolves there will be concomitant opportunities to develop agents that will specifically enhance graft survival with minimal complications to the host.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.